Source: Eur Respir J 2015; 46: 1202-1205



Rating:

Share or cite this content

Citations should be made in the following way:
Wang David, Lintzeris Nicholas, Leung Stefanie, Haber Paul S., Yee Brendon J., Grunstein Ronald R.. Reversal of central sleep apnoea with change from methadone to buprenorphine-naloxone: a case report. Eur Respir J 2015; 46: 1202-1205

Member's Comments

No comment yet.

Related content which might interest you: Does chronic opioid therapy alter the pattern of sleep apnea? Source: Eur Respir J 2004; 24: Suppl. 48, 446s Year: 2004 Treatment effects of sleep apnoea: where are we now? Source: Eur Respir Rev 2007; 16: 146-168 Year: 2007 Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem Source: Eur Respir J, 50 (6) 1701344; 10.1183/13993003.01344-2017 Year: 2017 Reported but not measured sleep latency predicts successful CPAP therapy in patients with obstructive sleep apnoea Source: Eur Respir J 2002; 20: Suppl. 38, 101s Year: 2002 Compliance in sleep apnoea therapy: influence of home care support and pressure mode Source: Eur Respir J 2009; 33: 804-811 Year: 2009 CPAP treatment for sleep apnea syndrome: compliance increases with very long term use Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005 Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study Source: Eur Respir J 2009; 33: 1062-1067 Year: 2009 Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study Source: Eur Respir J 2013; 41: 360-367 Year: 2013 When CPAP is stopped: what are the “on switches” of sleep apnoea? Source: Eur Respir J 2014; 43: 1227-1229 Year: 2014 Positional therapy for obstructive sleep apnea: do your patients use it at home? Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 The 5-min pupillary alertness test is sensitive to modafinil: a placebo controlled study in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment Source: Eur Respir J 2013; 41: 593-600 Year: 2013 Duration of CPAP use in the 1st night of treatment predicts success of therapy in patients with the sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 100s Year: 2002 Morphine alters respiratory control but not other key obstructive sleep apnoea phenotypes: a randomised trial Source: Eur Respir J, 55 (6) 1901344; 10.1183/13993003.01344-2019 Year: 2020 Varenicline administration for smoking cessation may reduce apnea hypnea index in sleep apnea patients Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Sleep apnoea and driving: the patients’ perspective Source: ERS Conference Year: 2015 Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance database Source: Eur Respir J, 51 (1) 1701855; 10.1183/13993003.01855-2017 Year: 2018 Daytime sleepiness in patients on intrathecal chronic opioid (IT) therapy is not related to sleep disordered breathing (SDB) Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 Atypical patterns in portable monitoring for sleep apnoea: features of nocturnal epilepsy? Source: Eur Respir J 2013; 41: 368-375 Year: 2013 Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea Source: Eur Respir J, 53 (5) 1802351; 10.1183/13993003.02351-2018 Year: 2019